SPRY icon

ARS Pharmaceuticals

76 hedge funds and large institutions have $864M invested in ARS Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 10 closing their positions.

Holders
76
Holders Change
+8
Holders Change %
+11.76%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
18
Increased
25
Reduced
19
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
AIG
76
American International Group
New York
$220 -$8 -265 -4%
LGM
77
Logos Global Management
California
-$5.45M -125,000 Closed
VA
78
VR Adviser
New York
-$3.71M -85,000 Closed
Bank Julius Baer & Co
79
Bank Julius Baer & Co
Switzerland
-$1.23M -28,187 Closed
CCM
80
CAAS Capital Management
New York
-$1.09M -25,000 Closed
Alyeska Investment Group
81
Alyeska Investment Group
Illinois
-$1.09M -25,000 Closed
ZP
82
Zimmer Partners
New York
-$436K -10,000 Closed
VOYA Investment Management
83
VOYA Investment Management
Georgia
-$233K -5,350 Closed
MLICM
84
Metropolitan Life Insurance Company (MetLife)
New York
-$176K -4,038 Closed
SO
85
STRS Ohio
Ohio
-$135K -3,100 Closed
Bank of Montreal
86
Bank of Montreal
Ontario, Canada
-$16K -390 Closed